Brief: India's Morepen Laboratories March Qtr Consol Net Profit Rises
22/06/2020 12:24
June 22 (Reuters) - Morepen Laboratories Ltd MORL.NS :
* MARCH QUARTER CONSOL NET PROFIT 110.2 MILLION RUPEES
VERSUS
104.9 MILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.07
BILLION
RUPEES VERSUS 2.19 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE9YqH34
Further company coverage: MORL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall